JAK inhibitors associated with aggressive lymphoma

(American Society of Hematology) Austrian researchers have discovered that a small number of patients taking targeted drugs known as Janus kinase (JAK) inhibitors to treat myelofibrosis may develop aggressive lymphomas.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news